SCHEMBL9490505

SCHEMBL9490505

CCCCCC(N)CCC[C@H](N)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 2/20 0.59
GRIK2 Q13002 2/20 0.59
SLC1A2 P43004 2/20 0.59
SLC1A1 P43005 2/20 0.59
GSR P00390 1/20 0.55
NOD1 Q9Y239 2/20 0.53
SLC1A3 P43003 1/20 0.52
ALDH1A1 P00352 1/20 0.52
DDAH1 O94760 2/20 0.51
S1PR2 O95136 5/20 0.50
S1PR1 P21453 5/20 0.50
S1PR3 Q99500 5/20 0.50
S1PR4 O95977 4/20 0.50
ARG2 P78540 4/20 0.50
ARG1 P05089 3/20 0.50
NOS1 P29475 3/20 0.49
NOS3 P29474 2/20 0.49
NOS2 P35228 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27608915 0.98 GRIK1 (0.61) GRIK1GRIK2SLC1A2SLC1A1GSR
SCHEMBL28307137 0.98 GRIK1 (0.61) GRIK1GRIK2SLC1A2SLC1A1GSR
SCHEMBL28580679 0.98 GRIK1 (0.61) GRIK1GRIK2SLC1A2SLC1A1GSR
SCHEMBL5967305 0.92 GRIK1 (0.68) GRIK1GRIK2SLC1A2SLC1A1GSR
SCHEMBL2730539 0.92 GRIK1 (0.68) GRIK1GRIK2SLC1A2SLC1A1GSR
SCHEMBL38735 0.92 GRIK1 (0.68) GRIK1GRIK2SLC1A2SLC1A1GSR
SCHEMBL23531056 0.90 GRIK1 (0.69) GRIK1GRIK2SLC1A2SLC1A1GSR
SCHEMBL262931 0.90 GRIK1 (0.69) GRIK1GRIK2SLC1A2SLC1A1GSR
SCHEMBL3696105 0.90 GRIK1 (0.69) GRIK1GRIK2SLC1A2SLC1A1GSR
SCHEMBL5478969 0.90 GRIK1 (0.69) GRIK1GRIK2SLC1A2SLC1A1GSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0249169-B1 PEPTIDES INFLUENCING DIURESE AND NATRIURESE, PROCESS FOR THEIR PREPARATION, AGENTS CONTAINING THEM AND THEIR USE HOECHST AKTIENGESELLSCHAFT (DE) 1993-01-20 EP claimed
US-5011825-A Treatment of hypertension, diabetes, edema HOECHST AKTIENGESELLSCHAFT (DE) 1991-04-30 US claimed
CN-87102304-A Pharmaceutical preparation containing compounds with antidementia effect and its application in preventing and treating cognitive dysfunction 1987-12-30 CN claimed
CN-101611053-B Anti-angiogenic compounds COVX TECHNOLOGIES IRELAND LTD 2015-06-03 CN disclosed
CN-101611053-A Anti-angiogenic compounds COVX TECHNOLOGIES IRELAND LTD (IE) 2009-12-23 CN disclosed
CN-1260207-C Basic amino acid derivatives as gelation agents AJINOMOTO KK (JP) 2006-06-21 CN disclosed
CN-1541998-A Basic amino acid derivatives as gelation agents ֮����ʽ���� 2004-11-03 CN disclosed
CN-1031267-C Compounds for anti-dementia medicine and its usage HOECHST AG (DE) 1996-03-13 CN disclosed
US-5011825-A Treatment of hypertension, diabetes, edema HOECHST AKTIENGESELLSCHAFT (DE) 1991-04-30 US disclosed
CN-87102304-A Pharmaceutical preparation containing compounds with antidementia effect and its application in preventing and treating cognitive dysfunction 1987-12-30 CN disclosed